Cat. No. 4285
Chemical Name: 7-Chloro-9-oxo-9H-indeno[1,2-b]pyra
Biological ActivityInhibitor of ubiquitin-specific protease (USP) 7 activity (IC50 = 424 nM). Displays uncompetitive inhibition. Also inhibits USP7-mediated p53 deubiquitination (IC50 = 0.8 μM). Stabilizes p53 and inhibits cancer cell growth; induces p53-dependent apoptosis in p53 wild type and null isogenic cancer cell lines.
Licensing InformationSold for research use only under patent license from Hybrigenics S.A.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Colland et al (2009) Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol.Cancer Ther. 8 2286. PMID: 19671755.
Colombo et al (2010) Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes. ChemMedChem 5 552. PMID: 20186914.
If you know of a relevant citation for this product please let us know.
Keywords: HBX 41108, supplier, HBX41108, ubiquitin-specific, proteases, usp7, selective, inhibitors, proteasome, ubiquitin, deubiquitination, hausp, herpesvirus-associated
Find multiple products by catalog number
New Products in this Area
Non-peptide, competitive angiotensin-converting enzyme (ACE) inhibitorAprotinin
Competitive serine protease inhibitorTCID
Selective ubiquitin C-terminal hydrolase-L3 (UCH-L3) inhibitor2-MPPA
Selective glutamate carboxypeptidase II (GCP II) inhibitor; orally bioavailableE 64
Potent and irreversible cysteine protease inhibitor
Tocris Product News
Novel USP7 inhibitor
Tocris is the exclusive supplier of HBX 41108 - a USP7 inhibitor licensed from Hybrigenics.